Patents by Inventor Daniel M. Canafax

Daniel M. Canafax has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CONTROLLED RELEASE GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS
    Publication number: 20210393529
    Abstract: Pharmaceutical granulations having a functional coating surrounding a core containing a water-soluble active pharmaceutical ingredient are disclosed. The functional coating provides for immediate release or controlled release of the active pharmaceutical ingredient. The pharmaceutical granulations can be used in oral pharmaceutical compositions.
    Type: Application
    Filed: June 17, 2021
    Publication date: December 23, 2021
    Inventors: SAMI KARABORNI, DANIEL M. CANAFAX, JIA-NING XIANG, WILLIAM W. XIANG, JAMES TIEN
  • PHARMACEUTICAL GRANULATIONS OF WATER-SOLUBLE ACTIVE PHARMACEUTICAL INGREDIENTS
    Publication number: 20210393537
    Abstract: Granulations with granules having a high loading of an active pharmaceutical ingredient are disclosed. The active pharmaceutical ingredient has a high aqueous water solubility. The granules have a narrow particle size distribution and a smooth exterior surface.
    Type: Application
    Filed: June 17, 2021
    Publication date: December 23, 2021
    Inventors: Sami KARABORNI, William W. XIANG, Daniel M. CANAFAX, Jia-Ning XIANG
  • Treating or preventing restless legs syndrome using prodrugs of GABA analogs
    Patent number: 8114909
    Abstract: Disclosed herein are methods of using prodrugs of gamma aminobutyric acid (GABA) analogs and pharmaceutical compositions thereof to treat or prevent restless legs syndrome in humans, and pharmaceutical compositions of prodrugs of GABA analogs useful in treating or preventing restless legs syndrome.
    Type: Grant
    Filed: September 17, 2004
    Date of Patent: February 14, 2012
    Assignee: XenoPort, Inc.
    Inventors: Ronald W. Barrett, Daniel M. Canafax
  • USES OF ACYLOXYALKYL CARBAMATE PRODRUGS OF TRANEXAMIC ACID
    Publication number: 20110060040
    Abstract: Methods of using acyloxyalkyl carbamate prodrugs of trans-4-(aminomethyl)-cyclohexanecarboxylic acid and pharmaceutical compositions thereof are disclosed.
    Type: Application
    Filed: August 17, 2010
    Publication date: March 10, 2011
    Inventors: Peter A. Virsik, Daniel M. Canafax
  • Use of Prodrugs of GABA B Agonists for Treating Neuropathic and Musculoskeletal Pain
    Publication number: 20090118365
    Abstract: Methods of treating neuropathic pain, musculoskeletal pain, and back spasm associated with musculoskeletal pain in a patient comprising orally administering a therapeutically effective dose of a prodrug of a GABAB agonist having a high oral bioavailability of the corresponding GABAB agonist are disclosed.
    Type: Application
    Filed: November 6, 2008
    Publication date: May 7, 2009
    Applicant: XenoPort, Inc
    Inventors: Joseph C. Benson, III, Peter A. Virsik, Daniel M. Canafax